Literature DB >> 21094162

Creating designed zinc-finger nucleases with minimal cytotoxicity.

Sivaprakash Ramalingam1, Karthikeyan Kandavelou, Raja Rajenderan, Srinivasan Chandrasegaran.   

Abstract

Zinc-finger nucleases (ZFNs) have emerged as powerful tools for delivering a targeted genomic double-strand break (DSB) to either stimulate local homologous recombination with investigator-provided donor DNA or induce gene mutations at the site of cleavage in the absence of a donor by nonhomologous end joining both in plant cells and in mammalian cells, including human cells. ZFNs are formed by fusing zinc-finger proteins to the nonspecific cleavage domain of the FokI restriction enzyme. ZFN-mediated gene targeting yields high gene modification efficiencies (>10%) in a variety of cells and cell types by delivering a recombinogenic DSB to the targeted chromosomal locus, using two designed ZFNs. The mechanism of DSB by ZFNs requires (1) two ZFN monomers to bind to their adjacent cognate sites on DNA and (2) the FokI nuclease domains to dimerize to form the active catalytic center for the induction of the DSB. In the case of ZFNs fused to wild-type FokI cleavage domains, homodimers may also form; this could limit the efficacy and safety of ZFNs by inducing off-target cleavage. In this article, we report further refinements to obligate heterodimer variants of the FokI cleavage domain for the creation of custom ZFNs with minimal cellular toxicity. The efficacy and efficiency of the reengineered obligate heterodimer variants of the FokI cleavage domain were tested using the green fluorescent protein gene targeting reporter system. The three-finger and four-finger zinc-finger protein fusions to the REL_DKK pair among the newly generated FokI nuclease domain variants appear to eliminate or greatly reduce the toxicity of designer ZFNs to human cells. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094162      PMCID: PMC3017627          DOI: 10.1016/j.jmb.2010.10.043

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains.

Authors:  J Smith; M Bibikova; F G Whitby; A R Reddy; S Chandrasegaran; D Carroll
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels.

Authors:  Shondra M Pruett-Miller; David W Reading; Shaina N Porter; Matthew H Porteus
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

3.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.

Authors:  Elena E Perez; Jianbin Wang; Jeffrey C Miller; Yann Jouvenot; Kenneth A Kim; Olga Liu; Nathaniel Wang; Gary Lee; Victor V Bartsevich; Ya-Li Lee; Dmitry Y Guschin; Igor Rupniewski; Adam J Waite; Carmine Carpenito; Richard G Carroll; Jordan S Orange; Fyodor D Urnov; Edward J Rebar; Dale Ando; Philip D Gregory; James L Riley; Michael C Holmes; Carl H June
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

4.  Precise genome modification in the crop species Zea mays using zinc-finger nucleases.

Authors:  Vipula K Shukla; Yannick Doyon; Jeffrey C Miller; Russell C DeKelver; Erica A Moehle; Sarah E Worden; Jon C Mitchell; Nicole L Arnold; Sunita Gopalan; Xiangdong Meng; Vivian M Choi; Jeremy M Rock; Ying-Ying Wu; George E Katibah; Gao Zhifang; David McCaskill; Matthew A Simpson; Beth Blakeslee; Scott A Greenwalt; Holly J Butler; Sarah J Hinkley; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov
Journal:  Nature       Date:  2009-04-29       Impact factor: 49.962

5.  Comparison of zinc finger nucleases for use in gene targeting in mammalian cells.

Authors:  Shondra M Pruett-Miller; Jon P Connelly; Morgan L Maeder; J Keith Joung; Matthew H Porteus
Journal:  Mol Ther       Date:  2008-03-04       Impact factor: 11.454

6.  Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.

Authors:  Hye Joo Kim; Hyung Joo Lee; Hyojin Kim; Seung Woo Cho; Jin-Soo Kim
Journal:  Genome Res       Date:  2009-05-21       Impact factor: 9.043

7.  Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification.

Authors:  Morgan L Maeder; Stacey Thibodeau-Beganny; Anna Osiak; David A Wright; Reshma M Anthony; Magdalena Eichtinger; Tao Jiang; Jonathan E Foley; Ronnie J Winfrey; Jeffrey A Townsend; Erica Unger-Wallace; Jeffry D Sander; Felix Müller-Lerch; Fengli Fu; Joseph Pearlberg; Carl Göbel; Justin P Dassie; Shondra M Pruett-Miller; Matthew H Porteus; Dennis C Sgroi; A John Iafrate; Drena Dobbs; Paul B McCray; Toni Cathomen; Daniel F Voytas; J Keith Joung
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 17.970

8.  High-frequency modification of plant genes using engineered zinc-finger nucleases.

Authors:  Jeffrey A Townsend; David A Wright; Ronnie J Winfrey; Fengli Fu; Morgan L Maeder; J Keith Joung; Daniel F Voytas
Journal:  Nature       Date:  2009-04-29       Impact factor: 49.962

9.  Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN).

Authors:  Jonathan E Foley; Jing-Ruey J Yeh; Morgan L Maeder; Deepak Reyon; Jeffry D Sander; Randall T Peterson; J Keith Joung
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

10.  Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases.

Authors:  Yannick Doyon; Jasmine M McCammon; Jeffrey C Miller; Farhoud Faraji; Catherine Ngo; George E Katibah; Rainier Amora; Toby D Hocking; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Sharon L Amacher
Journal:  Nat Biotechnol       Date:  2008-05-25       Impact factor: 54.908

View more
  29 in total

Review 1.  Gene therapy using stem cells.

Authors:  Erin R Burnight; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

Review 2.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

3.  Chapter 3 - Restoring Vision to the Blind: Gene Therapy for Vision Loss.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

4.  Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.

Authors:  Eva-Maria Händel; Katharina Gellhaus; Kafaitullah Khan; Christien Bednarski; Tatjana I Cornu; Felix Müller-Lerch; Robert M Kotin; Regine Heilbronn; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-12-14       Impact factor: 5.695

5.  Recent advances in the use of ZFN-mediated gene editing for human gene therapy.

Authors:  Srinivasan Chandrasegaran
Journal:  Cell Gene Ther Insights       Date:  2017-01-08

6.  Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases.

Authors:  Sivaprakash Ramalingam; Viktoriya London; Karthikeyan Kandavelou; Liudmila Cebotaru; William Guggino; Curt Civin; Srinivasan Chandrasegaran
Journal:  Stem Cells Dev       Date:  2012-10-19       Impact factor: 3.272

Review 7.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

8.  Zinc Finger Nucleases: Tailor-made for Gene Therapy.

Authors:  S-T Chou; Qixin Leng; A J Mixson
Journal:  Drugs Future       Date:  2012-03-01       Impact factor: 0.148

Review 9.  Making ends meet: targeted integration of DNA fragments by genome editing.

Authors:  Yutaka Yamamoto; Susan A Gerbi
Journal:  Chromosoma       Date:  2018-07-12       Impact factor: 4.316

Review 10.  Origins of Programmable Nucleases for Genome Engineering.

Authors:  Srinivasan Chandrasegaran; Dana Carroll
Journal:  J Mol Biol       Date:  2015-10-23       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.